Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Jazz to Buy Gentium for $1 Billion for Rare-Disease Drugs
Jazz to Buy Gentium for $1 Billion for Rare-Disease Drugs
Jazz to Buy Gentium for $1 Billion for Rare-Disease Drugs
Submitted by
admin
on December 19, 2013 - 6:07pm
Source:
Bloomberg
News Tags:
Jazz Pharmaceuticals
M&A
Gentium
Headline:
Jazz to Buy Gentium for $1 Billion for Rare-Disease Drugs
Do Not Allow Advertisers to Use My Personal information
